Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · IEX Real-Time Price · USD
5.94
+0.22 (3.85%)
At close: Mar 27, 2024, 4:00 PM
6.00
+0.06 (1.01%)
After-hours: Mar 27, 2024, 6:35 PM EDT

Zevra Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013
Revenue
10.4628.6513.2912.84000000
Revenue Growth (YoY)
-63.50%115.61%3.50%-------
Cost of Revenue
0.342.0600000000
Gross Profit
10.1226.5913.2912.84000000
Selling, General & Admin
15.348.77.9210.8212.5112.77148.884.531.35
Research & Development
19.6110.168.8419.4241.7620.5920.4713.9311.923.37
Other Operating Expenses
17.6602.132.951.6403.01000
Operating Expenses
52.6218.8618.933.1855.933.3737.4822.8116.444.72
Operating Income
-42.517.73-5.61-20.34-55.9-33.37-37.48-22.81-16.44-4.72
Interest Expense / Income
0.340.234.794.865.475.785.512.671.610.16
Other Expense / Income
-0.5116.022.4-0.65-4.784.29-26.4629.156.430.37
Pretax Income
-42.33-8.52-12.79-24.54-56.59-43.43-16.53-54.64-24.48-5.25
Income Tax
-0.790.03-0.03-0.02-0.13-0.04-0.020.03-0.02-0.02
Net Income
-41.54-8.56-12.76-24.52-56.47-43.39-16.52-54.66-24.46-5.23
Preferred Dividends
054.3400000000
Net Income Common
-41.54-62.9-12.76-24.52-56.47-43.39-16.52-54.66-24.46-5.23
Shares Outstanding (Basic)
343042111000
Shares Outstanding (Diluted)
343042111000
Shares Change
15.87%647.71%114.79%65.39%22.36%0.38%98.10%209.47%--
EPS (Basic)
-1.20-2.11-3.21-13.23-50.39-47.36-18.08-118.72-164.32-35.20
EPS (Diluted)
-1.20-2.11-3.21-13.23-50.39-47.36-18.08-118.72-164.32-35.20
Free Cash Flow
-18.8110.34-1.97-23.76-54.22-33.28-30.42-20.4-14.72-4.36
Free Cash Flow Per Share
-0.550.35-0.49-12.82-48.39-36.34-33.34-44.30-98.90-29.30
Gross Margin
96.72%92.81%100.00%100.00%------
Operating Margin
-406.44%26.98%-42.21%-158.40%------
Profit Margin
-397.24%-219.54%-96.03%-191.00%------
Free Cash Flow Margin
-179.86%36.08%-14.84%-185.08%------
EBITDA
-41.05-8.04-7.74-19.38-50.8-37.32-10.85-51.88-22.8-5.02
EBITDA Margin
-392.52%-28.06%-58.22%-150.96%------
Depreciation & Amortization
0.940.260.270.30.320.340.180.080.080.07
EBIT
-41.99-8.3-8.01-19.69-51.12-37.65-11.02-51.97-22.87-5.09
EBIT Margin
-401.55%-28.95%-60.27%-153.33%------
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).